Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (335)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
29
2025
186
13.060
 Why?
Anticonvulsants
20
2025
133
8.970
 Why?
Seizures
24
2025
208
6.210
 Why?
Tuberous Sclerosis
8
2025
39
4.330
 Why?
Spasms, Infantile
11
2025
30
4.210
 Why?
Cannabidiol
8
2025
43
4.010
 Why?
Status Epilepticus
6
2021
36
3.320
 Why?
Epilepsies, Myoclonic
5
2024
14
3.090
 Why?
Mutation
16
2023
1351
3.020
 Why?
Deep Brain Stimulation
4
2025
43
2.820
 Why?
Humans
117
2025
52332
2.660
 Why?
Electroencephalography
18
2024
312
2.480
 Why?
Child
42
2025
7158
2.190
 Why?
Intellectual Disability
5
2023
127
2.180
 Why?
Brain
10
2024
1323
2.110
 Why?
Hemiplegia
3
2021
12
2.000
 Why?
Developmental Disabilities
5
2019
121
1.680
 Why?
Epilepsy, Absence
3
2019
11
1.630
 Why?
Magnetic Resonance Imaging
16
2025
1543
1.600
 Why?
Infant
24
2025
3686
1.570
 Why?
Genetic Therapy
2
2025
120
1.490
 Why?
Algorithms
2
2025
667
1.390
 Why?
Tumor Suppressor Proteins
3
2023
132
1.390
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.390
 Why?
Nervous System Malformations
3
2020
16
1.380
 Why?
Folate Receptor 1
2
2022
27
1.350
 Why?
Child, Preschool
22
2025
4031
1.310
 Why?
Infant, Newborn, Diseases
2
2020
56
1.270
 Why?
Epilepsies, Partial
2
2022
14
1.270
 Why?
Ketamine
2
2020
59
1.260
 Why?
Vagus Nerve Stimulation
2
2025
14
1.150
 Why?
Neurocutaneous Syndromes
2
2019
6
1.140
 Why?
Cadherins
2
2019
63
1.120
 Why?
Cerebral Arteries
2
2019
30
1.050
 Why?
Epilepsy, Generalized
2
2023
9
1.030
 Why?
Vigabatrin
3
2024
3
1.020
 Why?
Sirolimus
2
2017
67
1.010
 Why?
Angiofibroma
2
2015
5
0.980
 Why?
Facial Neoplasms
2
2015
22
0.960
 Why?
Male
37
2025
26696
0.950
 Why?
Treatment Outcome
13
2025
5407
0.950
 Why?
Nerve Tissue Proteins
2
2018
193
0.950
 Why?
Valproic Acid
2
2022
35
0.940
 Why?
Neurosurgical Procedures
2
2025
135
0.930
 Why?
Female
33
2025
28103
0.930
 Why?
Stroke
3
2019
509
0.900
 Why?
Fenfluramine
2
2024
8
0.900
 Why?
Randomized Controlled Trials as Topic
2
2024
594
0.890
 Why?
Dioxolanes
2
2024
15
0.890
 Why?
Thalamus
1
2024
35
0.880
 Why?
Pregnanolone
2
2023
6
0.860
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.810
 Why?
Quality Improvement
2
2022
222
0.780
 Why?
Aphasia
1
2022
33
0.770
 Why?
Nervous System Diseases
2
2021
94
0.750
 Why?
Chromosome Deletion
3
2019
142
0.740
 Why?
Abnormalities, Multiple
3
2023
167
0.740
 Why?
Emergencies
1
2021
81
0.710
 Why?
Pharmaceutical Preparations
1
2021
74
0.710
 Why?
Angelman Syndrome
1
2020
1
0.690
 Why?
Transition to Adult Care
1
2020
18
0.690
 Why?
Bone Diseases, Developmental
2
2023
17
0.670
 Why?
Tooth Abnormalities
2
2023
13
0.670
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.670
 Why?
Adolescent
15
2025
6692
0.660
 Why?
Oligonucleotides, Antisense
1
2020
29
0.660
 Why?
Phenobarbital
1
2020
17
0.660
 Why?
Flunarizine
1
2019
1
0.650
 Why?
Behavioral Symptoms
1
2019
4
0.650
 Why?
Immunologic Factors
1
2021
117
0.650
 Why?
Excitatory Amino Acid Antagonists
1
2020
46
0.650
 Why?
Ocular Physiological Phenomena
1
2019
3
0.640
 Why?
Tetrasomy
1
2019
2
0.640
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.640
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.630
 Why?
Sneddon Syndrome
1
2019
3
0.630
 Why?
Livedo Reticularis
1
2019
5
0.630
 Why?
Oral Ulcer
1
2019
3
0.630
 Why?
Calcium Channel Blockers
1
2019
60
0.630
 Why?
Behcet Syndrome
1
2019
7
0.630
 Why?
Transposases
1
2019
10
0.620
 Why?
Andersen Syndrome
1
2019
1
0.620
 Why?
Spinal Cord Diseases
1
2019
39
0.620
 Why?
Hydrocephalus
1
2019
43
0.620
 Why?
Receptors, GABA-B
1
2019
12
0.610
 Why?
Vitiligo
1
2019
8
0.610
 Why?
Leukoencephalopathies
1
2019
14
0.610
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.610
 Why?
Nephrotic Syndrome
2
2017
19
0.610
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.610
 Why?
Edema
1
2019
65
0.600
 Why?
Migraine Disorders
2
2020
47
0.600
 Why?
Cerebral Infarction
1
2018
34
0.600
 Why?
Electron Transport Complex IV
1
2018
24
0.600
 Why?
Muscle Weakness
1
2019
45
0.600
 Why?
Cannabinoid Receptor Agonists
1
2019
51
0.600
 Why?
Physicians
1
2022
240
0.600
 Why?
Optic Atrophy
1
2018
16
0.590
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.590
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.590
 Why?
Photic Stimulation
1
2018
56
0.590
 Why?
Shab Potassium Channels
1
2018
2
0.590
 Why?
Alopecia
1
2019
38
0.590
 Why?
Brain Edema
1
2018
36
0.580
 Why?
Parents
1
2021
331
0.580
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.570
 Why?
Thrombocytopenia
1
2019
89
0.570
 Why?
Myoclonus
1
2018
9
0.570
 Why?
Artifacts
1
2018
55
0.570
 Why?
Autoimmune Diseases
1
2019
86
0.570
 Why?
Biomedical Research
1
2021
256
0.570
 Why?
Mitochondrial Diseases
1
2018
45
0.560
 Why?
Neurodegenerative Diseases
1
2018
81
0.560
 Why?
Practice Guidelines as Topic
1
2020
485
0.550
 Why?
Hearing Loss, Sensorineural
1
2018
79
0.540
 Why?
Osteochondrodysplasias
1
2017
14
0.540
 Why?
Immunologic Deficiency Syndromes
1
2017
18
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
509
0.540
 Why?
Models, Biological
1
2020
743
0.530
 Why?
Arteriosclerosis
1
2017
54
0.530
 Why?
Carotid Artery Diseases
1
2017
31
0.530
 Why?
Infant, Newborn
6
2024
2828
0.530
 Why?
Phenotype
2
2021
799
0.530
 Why?
Drug Discovery
1
2017
93
0.520
 Why?
Child Development
1
2018
200
0.520
 Why?
Prenatal Exposure Delayed Effects
1
2018
196
0.510
 Why?
Cafe-au-Lait Spots
1
2016
2
0.510
 Why?
Skin
1
2019
418
0.500
 Why?
Williams Syndrome
1
2016
25
0.500
 Why?
Erythema Infectiosum
1
2015
3
0.500
 Why?
Corpus Callosum
2
2023
26
0.500
 Why?
Migraine with Aura
1
2015
5
0.500
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.500
 Why?
Pulmonary Embolism
1
2017
84
0.490
 Why?
Sinus Pericranii
1
2015
1
0.490
 Why?
Syndrome
6
2024
247
0.490
 Why?
Parvovirus B19, Human
1
2015
17
0.490
 Why?
Toes
1
2015
15
0.490
 Why?
Electrodiagnosis
1
2015
13
0.490
 Why?
SOS1 Protein
1
2015
2
0.490
 Why?
Crying
1
2015
4
0.490
 Why?
Moyamoya Disease
1
2015
7
0.490
 Why?
Hyperventilation
1
2015
8
0.490
 Why?
Iatrogenic Disease
1
2015
25
0.480
 Why?
Tuberculoma
1
2015
1
0.480
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.480
 Why?
Noonan Syndrome
1
2015
12
0.480
 Why?
Neurologic Examination
1
2015
73
0.480
 Why?
Encephalitis
1
2016
39
0.480
 Why?
Ocular Motility Disorders
1
2015
17
0.470
 Why?
Communication
3
2022
257
0.470
 Why?
Mutism
1
2015
3
0.470
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.470
 Why?
TOR Serine-Threonine Kinases
1
2015
82
0.470
 Why?
Repressor Proteins
2
2023
156
0.470
 Why?
Diagnosis, Differential
7
2020
1044
0.460
 Why?
Trisomy
1
2014
35
0.460
 Why?
Influenza, Human
1
2015
84
0.450
 Why?
Neurology
1
2015
35
0.450
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.450
 Why?
Energy Drinks
1
2014
6
0.450
 Why?
Vasoconstriction
1
2014
56
0.440
 Why?
Benzodiazepines
1
2014
71
0.440
 Why?
Osteomyelitis
1
2015
125
0.430
 Why?
Membrane Proteins
1
2016
340
0.430
 Why?
Sleep
1
2014
186
0.410
 Why?
Enzyme Inhibitors
1
2015
374
0.410
 Why?
Quality of Life
4
2025
868
0.400
 Why?
Magnetic Resonance Angiography
3
2019
67
0.390
 Why?
Immunosuppressive Agents
3
2019
243
0.380
 Why?
Consensus
2
2025
180
0.380
 Why?
Pediatrics
1
2015
292
0.370
 Why?
Retrospective Studies
8
2025
6576
0.360
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
79
0.350
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
133
0.330
 Why?
Clinical Trials as Topic
2
2024
468
0.330
 Why?
Caregivers
2
2021
238
0.310
 Why?
Recurrence
3
2019
672
0.310
 Why?
Echinocandins
1
2008
64
0.290
 Why?
Mycoses
1
2008
152
0.280
 Why?
Gastroesophageal Reflux
2
2019
48
0.270
 Why?
Antifungal Agents
1
2008
347
0.250
 Why?
Administration, Topical
2
2015
60
0.240
 Why?
Adult
6
2025
14137
0.240
 Why?
Seizures, Febrile
1
2024
2
0.230
 Why?
Meta-Analysis as Topic
1
2024
40
0.230
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
 Why?
Psychosurgery
1
2023
5
0.220
 Why?
Databases, Factual
2
2024
706
0.220
 Why?
Laser Therapy
1
2023
76
0.200
 Why?
Speech Disorders
1
2022
16
0.200
 Why?
Ethosuximide
1
2022
5
0.200
 Why?
Clonazepam
1
2022
6
0.200
 Why?
Electrodes, Implanted
1
2022
32
0.200
 Why?
Cluster Analysis
1
2023
232
0.200
 Why?
Stereotaxic Techniques
1
2022
40
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
27
0.190
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Palliative Care
1
2024
214
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
 Why?
Freedom
1
2021
3
0.190
 Why?
Folic Acid
1
2022
136
0.180
 Why?
Diazepam
1
2021
17
0.180
 Why?
Drug Interactions
1
2022
205
0.180
 Why?
Fibroma
1
2021
40
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
30
0.180
 Why?
Personal Satisfaction
1
2021
75
0.180
 Why?
Soft Tissue Neoplasms
1
2021
55
0.170
 Why?
Risk Factors
2
2020
3872
0.170
 Why?
Dihydroergotamine
1
2020
5
0.170
 Why?
Brain Diseases
1
2021
79
0.170
 Why?
Perception
1
2021
120
0.170
 Why?
Transcription Factors
2
2023
574
0.170
 Why?
Mental Disorders
1
2025
428
0.170
 Why?
Facies
2
2023
36
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
24
0.170
 Why?
Clinical Protocols
1
2020
108
0.160
 Why?
Treatment Failure
1
2020
122
0.160
 Why?
Anesthetics
1
2020
36
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Muscle Hypotonia
1
2019
23
0.160
 Why?
Learning
1
2021
161
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
30
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Qualitative Research
1
2021
362
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
29
0.160
 Why?
Patient-Centered Care
1
2021
140
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.160
 Why?
Ubiquitin-Protein Ligases
1
2020
140
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
 Why?
Ventricular Premature Complexes
1
2019
6
0.150
 Why?
Disease Management
1
2020
188
0.150
 Why?
Microcephaly
1
2019
41
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Referral and Consultation
1
2021
292
0.150
 Why?
Syncope
1
2019
30
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
17
0.150
 Why?
Facial Paralysis
1
2018
25
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.150
 Why?
Health Personnel
1
2021
252
0.150
 Why?
Acute Disease
1
2019
374
0.150
 Why?
Deglutition Disorders
1
2019
80
0.150
 Why?
Fatal Outcome
1
2019
196
0.150
 Why?
Video Recording
1
2018
79
0.140
 Why?
Fibrinolytic Agents
1
2019
127
0.140
 Why?
Frameshift Mutation
1
2018
18
0.140
 Why?
Combined Modality Therapy
1
2020
636
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
82
0.140
 Why?
India
1
2017
62
0.140
 Why?
Cerebellum
1
2018
126
0.140
 Why?
Platelet Aggregation Inhibitors
1
2019
181
0.140
 Why?
History, 21st Century
1
2017
59
0.140
 Why?
History, 20th Century
1
2017
96
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
77
0.130
 Why?
Pandemics
1
2021
585
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
91
0.130
 Why?
Animals
3
2022
13524
0.130
 Why?
Anti-Infective Agents
1
2017
106
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
 Why?
Hormones
1
2016
59
0.120
 Why?
Influenza B virus
1
2015
6
0.120
 Why?
Delayed Diagnosis
1
2016
30
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
19
0.120
 Why?
Arkansas
1
2021
2028
0.120
 Why?
North America
1
2015
73
0.120
 Why?
Cerebral Angiography
1
2015
87
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
78
0.120
 Why?
Complementary Therapies
1
2015
23
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.120
 Why?
Brain Waves
1
2014
19
0.110
 Why?
Drug Resistance
1
2015
65
0.110
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
460
0.110
 Why?
Headache
1
2014
76
0.110
 Why?
Mutation, Missense
1
2014
108
0.110
 Why?
Glutamine
1
2015
176
0.110
 Why?
Vomiting
1
2014
73
0.110
 Why?
Arginine
1
2015
182
0.100
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.100
 Why?
Analgesics
1
2014
107
0.100
 Why?
Diagnostic Errors
1
2013
68
0.100
 Why?
Evidence-Based Medicine
1
2013
261
0.090
 Why?
Inflammation
1
2016
642
0.090
 Why?
Pregnancy
1
2018
2674
0.090
 Why?
Signal Transduction
1
2017
1716
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Antineoplastic Agents
1
2017
1222
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
44
0.070
 Why?
Lipopeptides
1
2008
62
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
152
0.070
 Why?
Candidiasis
1
2008
113
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
85
0.070
 Why?
Kidney Diseases
1
2009
220
0.070
 Why?
Prospective Studies
2
2023
2428
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
 Why?
Observer Variation
1
2024
133
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
484
0.050
 Why?
Probability
1
2023
171
0.050
 Why?
Young Adult
2
2025
4318
0.050
 Why?
Neuroimaging
1
2023
93
0.050
 Why?
Potassium Channels
1
2021
32
0.050
 Why?
Registries
1
2024
580
0.040
 Why?
Reproducibility of Results
1
2024
1214
0.040
 Why?
Administration, Intravenous
1
2020
73
0.040
 Why?
Sleep Stages
1
2020
40
0.040
 Why?
Age of Onset
1
2020
109
0.040
 Why?
Cognition
1
2022
331
0.040
 Why?
Follow-Up Studies
1
2025
2269
0.040
 Why?
Immunohistochemistry
1
2021
985
0.040
 Why?
Aged
1
2025
10108
0.020
 Why?
Software
1
2013
279
0.020
 Why?
Internet
1
2013
262
0.020
 Why?
Middle Aged
1
2025
13011
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
107
0.020
 Why?
Colonoscopy
1
2009
108
0.020
 Why?
Prognosis
1
2009
2094
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (335) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department